Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age
Public ClinicalTrials.gov record NCT01857206. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Observer Blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Chicken Eggs (Fluvirin®), in Healthy Children and Adolescents 4 to 17 Years of Age.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy children and adolescents 4 to 17 years of age.
Study identification
- NCT ID
- NCT01857206
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,055 participants
Conditions and interventions
Interventions
- Mammalian cell based flu vaccine Biological
- Egg based flu vaccine Biological
Biological
Eligibility (public fields only)
- Age range
- 4 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2013 (Type not available)
- Primary completion
- Jun 2014 (Actual)
- Completion
- Jun 2014 (Actual)
- Last update posted
- Dec 5, 2014
2013 – 2014
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 320, Novartis Investigational Site | Mobile | Alabama | 36608 | — |
| 312, Novartis Investigational Site | Ponte Vedra | Florida | 32081 | — |
| 313, Novartis Investigational Site | Augusta | Kansas | 67010 | — |
| 305, Novartis Investigational Site | Newton | Kansas | 67114 | — |
| 302, Novartis Investigational Site | Wichita | Kansas | 67205 | — |
| 301, Novartis Investigational Site | Wichita | Kansas | 67207 | — |
| 311, Novartis Investigational Site | Fremont | Nebraska | 68025 | — |
| 308, Novartis Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| 317, Novartis Investigational Site | Cleveland | Ohio | 44121 | — |
| 309, Novartis Investigational Site | Tulsa | Oklahoma | 74127 | — |
| 314, Novartis Investigational Site | Warwick | Rhode Island | 02886 | — |
| 319, Novartis Investigational Site | Mt. Pleasant | South Carolina | 29464 | — |
| 310, Novartis Investigational Site | Bristol | Tennessee | 37620 | — |
| 318, Novartis Investigational Site | Nashville | Tennessee | 37203 | — |
| 304, Novartis Investigational Site | Salt Lake City | Utah | 84109 | — |
| 306, Novartis Investigational Site | Salt Lake City | Utah | 84121 | — |
| 315, Novartis Investigational Site | Salt Lake City | Utah | 84124 | — |
| 303, Novartis Investigational Site | South Jordan | Utah | 84095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01857206, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2014 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01857206 live on ClinicalTrials.gov.